Research graph
References from Structure-guided discovery of novel ERα-binding peptides with in vitro antiproliferative activity. Local targets link to admitted publications; unresolved targets remain external evidence.
Genetic liability to multiple factors and uterine leiomyoma risk: a mendelian randomization study
10.3389/fendo.2023.1133260 · 2023 · External reference
10.1089/jwh.2018.7076
10.1089/jwh.2018.7076 · External reference
10.1007/s43032-022-00911-4
10.1007/s43032-022-00911-4 · External reference
Uterine fibroids: diagnosis and treatment
2017 · External reference
10.1080/14656566.2023.2248890
10.1080/14656566.2023.2248890 · External reference
10.1002/ijgo.13102
10.1002/ijgo.13102 · External reference
10.1007/s40265-023-01958-6
10.1007/s40265-023-01958-6 · External reference
Estrogen receptor alpha mutations, truncations, heterodimers, and therapies
10.1210/endocr/bqae051 · 2024 · External reference
Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα-positive breast cancer
10.3389/fonc.2025.1513225 · 2025 · External reference
10.3390/ijms20153718
10.3390/ijms20153718 · External reference
10.1042/ebc20200167
10.1042/ebc20200167 · External reference
Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha
10.1007/s00894-014-2338-x · 2014 · External reference
10.1038/nrd1551
10.1038/nrd1551 · External reference
ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
10.1038/s41523-022-00470-6 · 2022 · External reference
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor α coactivator binding
10.1021/jm030404c · 2004 · External reference
10.1016/j.steroids.2014.06.008
10.1016/j.steroids.2014.06.008 · External reference
10.1038/s41388-018-0284-2
10.1038/s41388-018-0284-2 · External reference
Targeted degradation of the estrogen receptor α through unconventional coactivator binding site (CBS)
10.1021/acs.jmedchem.5c00495 · 2025 · External reference
10.1021/acschembio.7b01016
10.1021/acschembio.7b01016 · External reference
10.1128/mcb.00118-10
10.1128/mcb.00118-10 · External reference
Disproportional body growth in female estrogen receptor-alpha-inactivated mice
10.1006/bbrc.1999.1711 · 1999 · External reference
10.1016/j.fertnstert.2012.06.056
10.1016/j.fertnstert.2012.06.056 · External reference
10.3390/ijms24065752
10.3390/ijms24065752 · External reference
10.1038/s41388-018-0165-8
10.1038/s41388-018-0165-8 · External reference
miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia
10.1016/j.leukres.2015.11.016 · 2016 · External reference
10.3390/md16070236
10.3390/md16070236 · External reference
10.2174/1389201024666230821103601
10.2174/1389201024666230821103601 · External reference
10.4155/fmc-2016-0143
10.4155/fmc-2016-0143 · External reference
10.2174/1570180819666220922103109
10.2174/1570180819666220922103109 · External reference
High-resolution MD simulation studies to get mechanistic insights into the urea-induced denaturation of human sphingosine kinase 1
10.2174/1568026621666211105095731 · 2021 · External reference
10.3390/ijms241310684
10.3390/ijms241310684 · External reference
GnRH analogs for the treatment of heavy menstrual bleeding associated with uterine fibroids
2023 · External reference
10.1021/jacs.1c12075
10.1021/jacs.1c12075 · External reference
K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation
10.1038/s41598-025-06676-5 · 2025 · External reference
10.1021/acs.jmedchem.3c01572
10.1021/acs.jmedchem.3c01572 · External reference
The ACPYPE web server for small-molecule MD topology generation
10.1093/bioinformatics/btad350 · 2023 · External reference
10.1002/prot.22711
10.1002/prot.22711 · External reference
10.1021/acs.jpcb.1c09424
10.1021/acs.jpcb.1c09424 · External reference
10.1016/j.csbj.2023.09.024
10.1016/j.csbj.2023.09.024 · External reference
The development and optimisation of an HPLC-based in vitro serum stability assay for a calcitonin gene-related peptide receptor antagonist peptide
10.1002/psc.3539 · 2024 · External reference
10.1002/adfm.201904969
10.1002/adfm.201904969 · External reference
10.1093/clinchem/hvaf043
10.1093/clinchem/hvaf043 · External reference
10.1016/j.ijbiomac.2020.07.280
10.1016/j.ijbiomac.2020.07.280 · External reference
10.1016/j.ijbiomac.2020.05.168
10.1016/j.ijbiomac.2020.05.168 · External reference
10.1016/j.jtbi.2015.03.035
10.1016/j.jtbi.2015.03.035 · External reference
10.1021/acs.chemrev.9b00055
10.1021/acs.chemrev.9b00055 · External reference
10.1517/17460441.2015.1032936
10.1517/17460441.2015.1032936 · External reference
10.1021/acs.jmedchem.7b00732
10.1021/acs.jmedchem.7b00732 · External reference
Characterization of novel small molecule inhibitors of estrogen receptor-activation function 2 (ER-AF2)
10.1186/s13058-024-01926-2 · 2024 · External reference
10.1016/j.ijbiomac.2015.12.072
10.1016/j.ijbiomac.2015.12.072 · External reference
10.1016/j.ijbiomac.2017.10.143
10.1016/j.ijbiomac.2017.10.143 · External reference
10.1080/14756366.2019.1692828
10.1080/14756366.2019.1692828 · External reference
In silico studies on psilocybin drug derivatives against SARS-CoV-2 and cytokine storm of human interleukin-6 receptor
10.3389/fimmu.2021.794780 · 2021 · External reference
